C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/06 (2006.01) A61K 31/427 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2592004
The invention relates to the use of compounds of general formula (I), in which R1, R2 and X are as defined in the description for the preparation of pharmaceutical compositions for the treatment of pathologies in which inhibition of the interaction between HIF-1.alpha. and p300 is beneficial, in particular as antiangiogenic medicaments for the therapy of solid tumors.
L'invention concerne l'utilisation de composés de formule générale (I), dans laquelle R1, R2 et X sont tels que définis dans la description, pour la préparation de compositions pharmaceutiques destinées à traiter des pathologies dans lesquelles une inhibition de l'interaction entre HIF-1.alpha. et p300 est bénéfique, en particulier comme médicaments antiangiogéniques en traitement de tumeurs solides.
Cassin Mara
Colella Gennaro
de Munari Sergio
Grugni Mario
Cell Therapeutics Europe S.r.l.
Sim & Mcburney
LandOfFree
Use of thiazolidinone derivatives as antiangiogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of thiazolidinone derivatives as antiangiogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thiazolidinone derivatives as antiangiogenic agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2051066